RESUMO
The frequency of use of assist blood device as the "bridge" to the heart transplantation increased in last years. An assessment of results of first 7 implantations of assist circulation device using biventricular type "Excor" was made. The implantations were performed in Federal Almazov centre of the heart, blood and endocrinology. An observation period after implantation was since 11 till 301 days. The heart transplantation of 4 patients was carried out in different terms after implantation. One of the patients passed away on the fifth day due to the pulmonary embolism. Another patient died on the eleventh day after the implantation because of multiple organ failure against the background of severe chronic cardiac failure. The waiting list of heart transplantation includes 2 patients.
Assuntos
Circulação Assistida , Insuficiência Cardíaca , Transplante de Coração/métodos , Coração Auxiliar , Adolescente , Adulto , Circulação Assistida/instrumentação , Circulação Assistida/métodos , Desenho de Equipamento , Feminino , Insuficiência Cardíaca/mortalidade , Insuficiência Cardíaca/fisiopatologia , Insuficiência Cardíaca/cirurgia , Humanos , Imunossupressores/uso terapêutico , Masculino , Período Pós-Operatório , Cuidados Pré-Operatórios/métodos , Índice de Gravidade de Doença , Análise de Sobrevida , Resultado do Tratamento , Listas de EsperaRESUMO
At the present time heart transplantation is considered to be the operation of choice in treatment of patients with terminal stage of chronic heart failure. Results of the first 5 heart transplantations made in the Federal Center of the heart, blood and endocrinology named after V. A. Almazov are assessed. There were no perioperational lethality and complications at the hospital stage. An analysis of the long-term results has shown effectiveness of heart transplantations in treatment of severe heart pathology.
